Healthcare provider profile · identity verified

Dale E Goins, MD

Allopathic & Osteopathic Physicians|Family Medicine · HOPE, AR · NPI 1063402485

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Dale E Goins, MD received $33.51 in general payments during 2025 across 2 reported records.

AstraZeneca Pharmaceuticals LP accounted for 51.2% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Mounjaro.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BEVESPI AEROSPHERE as an associated drug or biological on 763 records involving 473 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Bevespi Aerosphere by this doctor in 2024.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 43 claims for Farxiga by this doctor in 2024.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 30 claims for Symbicort by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Jardiance by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 28 claims for Mounjaro by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$33.51

2 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
AstraZeneca Pharmaceuticals LP	Unresolved — no canonical attribution shown	$17.15	51.2%	1	2025
Lilly USA, LLC	Unresolved — no canonical attribution shown	$16.36	48.8%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$33.51	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
AIRSUPRA Normalized: airsupra	Drug	AstraZeneca Pharmaceuticals LP	$17.15	1	2025
Source payment records 2025-05-29 · AstraZeneca Pharmaceuticals LP · $17.15 · Open Payments source
MOUNJARO Normalized: mounjaro	Drug	Lilly USA, LLC	$16.36	1	2025
Source payment records 2025-10-30 · Lilly USA, LLC · $16.36 · Open Payments source
ZEPBOUND Normalized: zepbound	Drug	Lilly USA, LLC	$16.36	1	2025
Source payment records 2025-10-30 · Lilly USA, LLC · $16.36 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
MOUNJARO mounjaro	2025	Mounjaro	2024	28 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	BEVESPI AEROSPHERE open payments reported associated product	CMS Open Payments — General Payments 763 supporting records · 473 recipient NPIs · example record 1206131384	Bevespi Aerosphere · 2024 Exact normalized brand match · 1 Part D row	12	suppressed by CMS
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	FARXIGA open payments reported associated product	CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362	Farxiga · 2024 Exact normalized brand match · 1 Part D row	43	suppressed by CMS
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	SYMBICORT open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610	Symbicort · 2024 Exact normalized brand match · 1 Part D row	30	12
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557	Jardiance · 2024 Exact normalized brand match · 1 Part D row	17	suppressed by CMS
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	MOUNJARO open payments reported associated product	CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455	Mounjaro · 2024 Exact normalized brand match · 1 Part D row	28	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	943	120
Potassium Chloride	Potassium Chloride	790	141
Atorvastatin Calcium	Atorvastatin Calcium	769	136
Gabapentin	Gabapentin	628	117
Amlodipine Besylate	Amlodipine Besylate	621	115
Furosemide	Furosemide	613	110
Levothyroxine Sodium	Levothyroxine Sodium	587	86
Metformin Hcl	Metformin Hcl	558	95
Pantoprazole Sodium	Pantoprazole Sodium	514	115
Meloxicam	Meloxicam	470	99
Lisinopril	Lisinopril	433	80
Omeprazole	Omeprazole	420	59
Eliquis	Apixaban	368	46
Tamsulosin Hcl	Tamsulosin Hcl	363	53
Metoprolol Tartrate	Metoprolol Tartrate	362	62
Losartan Potassium	Losartan Potassium	361	75
Tramadol Hcl	Tramadol Hcl	340	67
Trazodone Hcl	Trazodone Hcl	327	56
Albuterol Sulfate Hfa	Albuterol Sulfate	323	74
Sertraline Hcl	Sertraline Hcl	305	50
Divalproex Sodium	Divalproex Sodium	300	31
Metoprolol Succinate	Metoprolol Succinate	298	59
Pravastatin Sodium	Pravastatin Sodium	264	38
Carvedilol	Carvedilol	262	49
Mirtazapine	Mirtazapine	259	42
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	258	54
Alprazolam	Alprazolam	256	37
Quetiapine Fumarate	Quetiapine Fumarate	247	22
Risperidone	Risperidone	240	20
Clopidogrel	Clopidogrel Bisulfate	238	50
Simvastatin	Simvastatin	232	37
Hydrochlorothiazide	Hydrochlorothiazide	207	40
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	206	57
Famotidine	Famotidine	203	38
Venlafaxine Hcl	Venlafaxine Hcl	174	25
Levetiracetam	Levetiracetam	171	21
Donepezil Hcl	Donepezil Hcl	170	23
Duloxetine Hcl	Duloxetine Hcl	170	25
Montelukast Sodium	Montelukast Sodium	168	25
Escitalopram Oxalate	Escitalopram Oxalate	166	31
Clonidine Hcl	Clonidine Hcl	163	33
Clonazepam	Clonazepam	160	25
Tizanidine Hcl	Tizanidine Hcl	159	29
Allopurinol	Allopurinol	158	33
Lorazepam	Lorazepam	158	36
Pioglitazone Hcl	Pioglitazone Hcl	152	33
Citalopram Hbr	Citalopram Hydrobromide	143	20
Levofloxacin	Levofloxacin	141	100
Glipizide	Glipizide	140	28
Topiramate	Topiramate	138	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	131	15
Nabumetone	Nabumetone	127	31
Pregabalin	Pregabalin	125	31
Buspirone Hcl	Buspirone Hcl	123	30
Memantine Hcl	Memantine Hcl	120	18
Diclofenac Sodium	Diclofenac Sodium	115	27
Venlafaxine Hcl Er	Venlafaxine Hcl	114	16
Celecoxib	Celecoxib	113	26
Benztropine Mesylate	Benztropine Mesylate	109	suppressed
Carbamazepine	Carbamazepine	107	14
Diazepam	Diazepam	102	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	102	18
Prednisone	Prednisone	97	42
Januvia	Sitagliptin Phosphate	91	suppressed
Spironolactone	Spironolactone	86	15
Lantus	Insulin Glargine,hum.Rec.Anlog	83	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	83	21
Nifedipine Er	Nifedipine	83	19
Temazepam	Temazepam	83	12
Finasteride	Finasteride	82	13
Phenytoin Sodium Extended	Phenytoin Sodium Extended	82	11
Acetaminophen-Codeine	Acetaminophen With Codeine	81	23
Ropinirole Hcl	Ropinirole Hcl	81	13
Naproxen	Naproxen	80	22
Baclofen	Baclofen	79	14
Meclizine Hcl	Meclizine Hcl	79	24
Zolpidem Tartrate	Zolpidem Tartrate	79	14
Fluticasone Propionate	Fluticasone Propionate	78	25
Dicyclomine Hcl	Dicyclomine Hcl	77	13
Rosuvastatin Calcium	Rosuvastatin Calcium	72	13
Nystatin	Nystatin	71	31
Hydralazine Hcl	Hydralazine Hcl	70	15
Hydroxyzine Hcl	Hydroxyzine Hcl	70	16
Oxybutynin Chloride	Oxybutynin Chloride	70	15
Ibuprofen	Ibuprofen	69	18
Esomeprazole Magnesium	Esomeprazole Magnesium	64	suppressed
Ozempic	Semaglutide	63	12
Myrbetriq	Mirabegron	62	suppressed
Lamotrigine	Lamotrigine	61	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	61	21
Ondansetron Hcl	Ondansetron Hcl	59	23
Linzess	Linaclotide	58	suppressed
Oxycodone Hcl	Oxycodone Hcl	58	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	57	14
Valproic Acid	Valproic Acid (As Sodium Salt)	57	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	56	suppressed
Atenolol	Atenolol	56	suppressed
Fluconazole	Fluconazole	55	29
Oxcarbazepine	Oxcarbazepine	55	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	54	44
Valsartan	Valsartan	54	suppressed
Azithromycin	Azithromycin	53	45
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	53	13
Nortriptyline Hcl	Nortriptyline Hcl	53	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	52	11
Estradiol	Estradiol	51	suppressed
Bumetanide	Bumetanide	50	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	49	37
Diltiazem 24hr Er	Diltiazem Hcl	48	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	48	suppressed
Entresto	Sacubitril/Valsartan	47	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	47	31
Chlorthalidone	Chlorthalidone	46	suppressed
Novolin R	Insulin Regular, Human	46	suppressed
Glimepiride	Glimepiride	45	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	45	11
Nitroglycerin	Nitroglycerin	45	25
Warfarin Sodium	Warfarin Sodium	45	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	44	suppressed
Farxiga	Dapagliflozin Propanediol	43	suppressed
Clindamycin Hcl	Clindamycin Hcl	42	25
Propranolol Hcl	Propranolol Hcl	41	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	40	18
Oxybutynin Chloride Er	Oxybutynin Chloride	40	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	39	suppressed
Haloperidol	Haloperidol	39	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	38	suppressed
Sucralfate	Sucralfate	38	suppressed
Paroxetine Hcl	Paroxetine Hcl	37	suppressed
Amiodarone Hcl	Amiodarone Hcl	35	suppressed
Ondansetron Odt	Ondansetron	35	13
Phenobarbital	Phenobarbital	34	suppressed
Alendronate Sodium	Alendronate Sodium	33	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	33	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	32	suppressed
Carbamazepine Er	Carbamazepine	31	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	31	suppressed
Divalproex Sodium Er	Divalproex Sodium	31	suppressed
Doxepin Hcl	Doxepin Hcl	30	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	30	11
Olanzapine	Olanzapine	30	suppressed
Rexulti	Brexpiprazole	30	suppressed
Symbicort	Budesonide/Formoterol Fumarate	30	12
Ventolin Hfa	Albuterol Sulfate	30	11
Methocarbamol	Methocarbamol	29	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Mounjaro	Tirzepatide	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Digoxin	Digoxin	26	suppressed
Minocycline Hcl	Minocycline Hcl	26	suppressed
Cefuroxime	Cefuroxime Axetil	25	21
Lacosamide	Lacosamide	25	suppressed
Prazosin Hcl	Prazosin Hcl	25	suppressed
Amoxicillin	Amoxicillin	24	16
Benazepril Hcl	Benazepril Hcl	24	suppressed
Clonidine	Clonidine	24	suppressed
Clozapine	Clozapine	24	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	24	suppressed
Lactulose	Lactulose	24	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	24	24
Calcitriol	Calcitriol	23	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	23	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	23	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	22	suppressed
Fentanyl	Fentanyl	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Solifenacin Succinate	Solifenacin Succinate	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Acyclovir	Acyclovir	21	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	21	suppressed
Potassium Citrate Er	Potassium Citrate	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	20	20
Carbidopa-Levodopa	Carbidopa/Levodopa	20	suppressed
Epinephrine	Epinephrine	20	suppressed
Larin Fe	Norethindrone-E.Estradiol-Iron	20	suppressed
Latanoprost	Latanoprost	20	suppressed
Naltrexone Hcl	Naltrexone Hcl	20	suppressed
Labetalol Hcl	Labetalol Hcl	19	suppressed
Betamethasone Valerate	Betamethasone Valerate	18	suppressed
Dexlansoprazole Dr	Dexlansoprazole	18	suppressed
Ingrezza	Valbenazine Tosylate	18	suppressed
Jardiance	Empagliflozin	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Clotrimazole	Clotrimazole	16	suppressed
Premarin	Estrogens, Conjugated	16	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	15	suppressed
Captopril	Captopril	15	suppressed
Chlorpromazine Hcl	Chlorpromazine Hcl	15	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Levemir	Insulin Detemir	15	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	15	suppressed
Lumigan	Bimatoprost	15	suppressed
Primidone	Primidone	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Terbinafine Hcl	Terbinafine Hcl	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Tradjenta	Linagliptin	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Ascomp With Codeine	Codeine/Butalbital/Asa/Caffein	13	suppressed
Desmopressin Acetate	Desmopressin Acetate	13	suppressed
Humalog	Insulin Lispro	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Dofetilide	Dofetilide	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Humulin R	Insulin Regular, Human	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Jantoven	Warfarin Sodium	12	suppressed
Lubiprostone	Lubiprostone	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Zonisamide	Zonisamide	12	suppressed
Desmopressin Acetate	Desmopressin (Nonrefrigerated)	11	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	11	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	11	suppressed
Lurasidone Hcl	Lurasidone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$33.51 · 2 records	AstraZeneca Pharmaceuticals LP	AIRSUPRA, MOUNJARO, ZEPBOUND	5	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Mounjaro play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error